Wai Chin Chong

Children's National — United States

Medicine · Health Sciences

14h-index1.1kcitations57works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(28), Neuroblastoma Research and Treatments(12), ATP Synthase and ATPases Research(12), Cancer, Hypoxia, and Metabolism(8), Epigenetics and DNA Methylation(4)

Publications57 total

MTAP-Null Tumors: A Comprehensive Review on Synthetic Vulnerabilities and Therapeutic Strategies
Cells·2025· 1 citedOpen Access
MTAP-Null Tumors: A Comprehensive Review on Synthetic Vulnerabilities and Therapeutic Strategies
Universität Zürich, ZORA·2025Open Access
Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
2025Open Access
Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
2025Open Access
Dual treatment with Val-083 and AZD1775 shows potent anti-tumor activity in diffuse midline glioma models
npj Precision Oncology·2025· 1 citedOpen Access
Dual treatment with Val-083 and AZD1775 shows potent anti-tumor activity in diffuse midline glioma models
Universität Zürich, ZORA·2025Open Access
Supplementary Data from ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
2024Open Access
Supplementary Data from ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
2024Open Access
Supplementary Data from ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
2024Open Access
Supplementary Data from ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
2024Open Access
Data from ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
2024Open Access
MODL-03. THERAPEUTIC EFFICACY OF IMIPIRIDONES IN LYNCH SYNDROME-ASSOCIATED GLIOMAS
Neuro-Oncology·2024Open Access
NFS-22. INVESTIGATING MALIGNANT TRANSFORMATION IN NF1 PEDIATRIC GLIOMAS USING AN IPSCS-DERIVED CEREBRAL ORGANOID MODEL
Neuro-Oncology·2024· 1 citedOpen Access
NFS-10. ROLE OF CDKN2A CO-DELETION IN DRIVING TUMOR INVASIVENESS IN NF1 MUTANT GLIOMA
Neuro-Oncology·2024Open Access
MODL-04. ZEBRAFISH: THE FUTURE OF PEDIATRIC BRAIN CANCER RESEARCH
Neuro-Oncology·2024Open Access
Zebrafish—A Suitable Model for Rapid Translation of Effective Therapies for Pediatric Cancers
Cancers·2024· 8 citedOpen Access
EXTH-36. COMBINING ONC201 AND PAXALISIB FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA (DMG); THE PRECLINICAL RESULTS UNDERPINNING THE INTERNATIONAL PHASE II CLINICAL TRIAL (NCT05009992)
Neuro-Oncology·2023Open Access
Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype
Oncogene·2023· 3 citedOpen Access
SYST-15 GENERATION AND MULTI-DIMENSIONAL PROFILING OF A CHILDHOOD CANCER CELL LINE ATLAS DEFINES NEW THERAPEUTIC OPPORTUNITIES
Neuro-Oncology Advances·2023Open Access
Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Jason E. Cain(29), Javad Nazarian(27), Sridevi Yadavilli(24), Sarah Parackal(24), Ron Firestein(22), Matthew D. Dun(21), Nicholas A. Vitanza(20), Carl Koschmann(20), Sebastian M. Waszak(20), Sabine Mueller(20), Bryan W. Day(20), Evangeline R. Jackson(19), Ryan J. Duchatel(19), Dilana E. Staudt(19), Mika L. Persson(19), Abdul Mannan(19), Shaye Game(19), W. Samantha N. Jayasekara(19), Marion Le Grand(19), Padraic S. Kearney(19)